Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dexmedetomidine Versus Fentanyl as an Adjuvant to Bupivacaine in Saddle Block for Various Anal Surgeries: A Correlative Randomized Trial

NCT06216197 is registered in ClinicalTrials.gov with Zulekha Hospitals as lead sponsor.

NCT NCT06216197
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06216197 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dexmedetomidine Versus Fentanyl as an Adjuvant to Bupivacaine in Saddle Block for Various Anal Surgeries: A Correlative Randomized Trial
Lead sponsor
Zulekha Hospitals
Phase
Not applicable
Overall status
Completed
Start date
April 3, 2021
Completion date
December 4, 2022
Enrollment
58 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

regional anesthesia morbidity